Subject: Galen pre-seed: causal virtual-cell models for intervention prediction

Hi [Name],

I thought Galen was worth a look for the pre-seed round.

Galen is building causal virtual-cell models that predict how living cells respond to intervention, quantify confidence, and choose the next experiment most likely to teach the model. The pre-seed round funds the real human-cell proof loop: predictions committed before results, model-selected experiments, and a first partner-ready intervention-ranking product.

The first commercial wedge is intervention ranking for discovery teams deciding which biological changes deserve lab budget.

Public investor workspace: https://www.usegalen.com/preseed
Dedicated pre-seed domain: https://preseed.usegalen.com
Concise partner memo: https://www.usegalen.com/preseed/partner-memo.md
Public proof ledger: https://www.usegalen.com/preseed/proof-ledger.md
AI diligence prompt: https://www.usegalen.com/preseed/ai-diligence-prompt.txt
Private packet request: https://www.usegalen.com/preseed#data-room

The public proof supports controlled causal recovery and disciplined controls. The round funds the prospective human-cell proof loop, model-selected experiments, and a partner-ready intervention-ranking workflow.

This is worth a founder conversation for investors who believe intervention prediction is the valuable layer of the virtual-cell stack.